Newton, MA, United States of America

Perry Rosenthal

USPTO Granted Patents = 6 

Average Co-Inventor Count = 1.0

ph-index = 4

Forward Citations = 135(Granted Patents)


Location History:

  • Needham, MA (US) (2009)
  • Newton, MA (US) (2010 - 2018)

Company Filing History:


Years Active: 2009-2018

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Perry Rosenthal

Introduction

Perry Rosenthal is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of medical technology, particularly in the development of advanced delivery systems for therapeutic agents. With a total of 6 patents to his name, Rosenthal's work has the potential to improve patient outcomes in various medical applications.

Latest Patents

One of Rosenthal's latest patents is a sodium channel blocker delivery system with a scleral lens. This innovative scleral lens is designed to incorporate a sodium channel blocker or a sodium channel modulator within the pre-corneal tear film, positioned between the scleral lens and the cornea. This system aims to enhance the delivery of sodium channel blockers or modulators that have previously been underutilized due to poor bioavailability. The patent also outlines methods for utilizing this sodium channel blocker delivery system effectively.

Career Highlights

Perry Rosenthal has dedicated his career to advancing medical technology through innovative inventions. His work at the Boston Foundation for Sight has allowed him to focus on developing solutions that address critical needs in ocular health. His contributions have not only garnered patents but have also paved the way for new treatment options for patients suffering from various eye conditions.

Conclusion

Perry Rosenthal's inventive spirit and dedication to improving medical technology are evident in his work and patents. His sodium channel blocker delivery system represents a significant advancement in the field, showcasing his commitment to enhancing patient care through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…